AstraZeneca India, a pharmaceutical company, announced on Friday that the Drugs Controller General of India had given the go-ahead to commercialise its medication for the treatment of breast cancer. In adults with early breast cancer who have previously received neoadjuvant or adjuvant Continue Reading